<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="/rss/styles.xsl" type="text/xsl"?><rss version="2.0"><channel><title>Grounded News — health, pharma &amp; medical science</title><description>Primary-source health, pharma, and med-sci headlines (FDA, NIH, WHO, CMS, Nature Medicine, npj Digital Medicine, medRxiv), aggregated daily at drjeremytabernero.org/news. Every item links to its original source.</description><link>https://drjeremytabernero.org/</link><language>en-us</language><item><title>[Nature Medicine] Regulatory fragmentation as the hidden barrier to regional vaccine sovereignty</title><link>https://www.nature.com/articles/s41591-026-04580-7</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04580-7</guid><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] How to build an AI-driven digital organism</title><link>https://www.nature.com/articles/s41591-026-04595-0</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04595-0</guid><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] AI decision support is scaling-up fast — can the evidence keep up?</title><link>https://www.nature.com/articles/d41591-026-00040-4</link><guid isPermaLink="true">https://www.nature.com/articles/d41591-026-00040-4</guid><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Context-aware monitoring: rethinking comprehensive screening in the era of AI</title><link>https://www.nature.com/articles/s41746-026-03106-2</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03106-2</guid><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[medRxiv] Predictors of Brain Injury: The Performance of Biomechanical Head Acceleration Severity Metrics for Concussion Prediction in Men&apos;s and Women&apos;s Rugby League Players</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360260v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360260v1?rss=1</guid><description>Objective Describe and compare the biomechanical severity of head acceleration events (HAEs) associated with diagnosed concussion in elite men&apos;s and women&apos;s rugby league using instrumented mouthguards (iMGs) and evaluate the diagnostic accuracy and screening…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Evaluation and demonstration of a new tuberculosis diagnostic tool for Indonesia: Study protocol of the EVIDENT cluster randomised controlled trial</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360245v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360245v1?rss=1</guid><description>Introduction: Most people with tuberculosis (TB) reside in countries with limited resources for prompt TB diagnosis, resulting in diagnosis and treatment delays and ongoing community transmission. Current TB diagnostics rely on sputum, while some people with…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Child disciplining practices and their association with child stunting in Rwanda: insights from a population-based study</title><link>https://www.medrxiv.org/content/10.64898/2026.08.11.26360229v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.11.26360229v1?rss=1</guid><description>This study investigated the prevalence of physical and non-physical disciplining methods used by mothers of young children in Rwanda and examined their association with child stunting. The role of disciplining practices in child linear growth remains largely…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Study Protocol: Risk and resilience factors in problematic internet use among Sami and non-Sami adolescents in Finnmark, Arctic Norway: the role of social norms and ethnic identity</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360242v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360242v1?rss=1</guid><description>Problematic Internet Use (PIU)--marked by compulsive or maladaptive online behavior--is an emerging public health issue among adolescents and is associated with psychological distress, social difficulties, and academic problems. In Finnmark County, Norways…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Increased HIV incidence during Event-Driven PrEP compared to Daily PrEP in the Netherlands</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360235v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360235v1?rss=1</guid><description>Background Clinical trials demonstrated high efficacy of daily and event-driven oral pre-exposure prophylaxis (PrEP) in HIV prevention. Event-driven PrEP involves taking two tablets before and two times one tablet after sexual contact (2-1-1/on-demand). While…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Albuminuria-Predominant Kidney-Metabolic Discordance and Cardiovascular Mortality Despite Lower TyG: A Nationally Representative Cohort Study</title><link>https://www.medrxiv.org/content/10.64898/2026.08.11.26360225v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.11.26360225v1?rss=1</guid><description>BACKGROUND: Albuminuria and the triglyceride-glucose (TyG) index reflect distinct kidney and metabolic dimensions of cardiovascular-kidney-metabolic health. We tested whether a comparatively lower TyG attenuates albuminuria-associated mortality risk. METHODS:…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Forecasting laboratory measurements from longitudinal electronic health records</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360243v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360243v1?rss=1</guid><description>Forecasting a patient&apos;s laboratory measurements at future clinical visits from longitudinal electronic health records (EHRs) can support disease monitoring and treatment planning in the context of personalized medicine. However, accurate prediction remains…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[medRxiv] Interconnected Challenges in Dementia Caregiving: A Co-occurrence Network Analysis of Burden, Unmet Needs, and System Failures Among Caregivers</title><link>https://www.medrxiv.org/content/10.64898/2026.08.12.26360253v1?rss=1</link><guid isPermaLink="true">https://www.medrxiv.org/content/10.64898/2026.08.12.26360253v1?rss=1</guid><description>Background: Alzheimer&apos;s Disease and Related Dementias (ADRD) is a growing global public health challenge, and caregivers experience high rates of burden, unmet needs, and system failures. These challenges vary by caregiver role and relationship to the care…</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>Preprints</category></item><item><title>[Nature Medicine] Editorial Expression of Concern: Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury</title><link>https://www.nature.com/articles/s41591-026-04619-9</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04619-9</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] Frugal AI is the missing piece in cervical cancer screening</title><link>https://www.nature.com/articles/s41591-026-04568-3</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04568-3</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] Sleep as therapy</title><link>https://www.nature.com/articles/s41591-026-04582-5</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04582-5</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial</title><link>https://www.nature.com/articles/s41591-026-04564-7</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04564-7</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] OpenEvidence clinical question-answering platform: systematic review of early evaluations</title><link>https://www.nature.com/articles/s41746-026-03077-4</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03077-4</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Natural language processing application in electronic health records studies for psychosis: a systematic review</title><link>https://www.nature.com/articles/s41746-026-03125-z</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03125-z</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Phenomapping-derived tool to individualize the effect of sacubitril-valsartan in heart failure with preserved ejection fraction</title><link>https://www.nature.com/articles/s41746-026-03138-8</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03138-8</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Clinicians vs. artificial intelligence in patient outcome prediction in the intensive care unit</title><link>https://www.nature.com/articles/s41746-026-03132-0</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03132-0</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Automated limb motor assessment in Parkinson’s disease via a time-frequency state-space model</title><link>https://www.nature.com/articles/s41746-026-03120-4</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03120-4</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Post-treatment perspectives on digital CBT-I among heavy drinkers with insomnia: a qualitative study</title><link>https://www.nature.com/articles/s41746-026-03021-6</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03021-6</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[npj Digital Medicine] Diagnostic accuracy of large language models for rare diseases: a systematic review and meta-analysis</title><link>https://www.nature.com/articles/s41746-026-03109-z</link><guid isPermaLink="true">https://www.nature.com/articles/s41746-026-03109-z</guid><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[Nature Medicine] From RAS inhibitor resistance to rational combination strategies</title><link>https://www.nature.com/articles/s41591-026-04529-w</link><guid isPermaLink="true">https://www.nature.com/articles/s41591-026-04529-w</guid><pubDate>Tue, 11 Aug 2026 00:00:00 GMT</pubDate><category>Journals</category></item><item><title>[FDA] FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine</title><link>http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-prevent-new-world-screwworm-multiple-species-including</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-prevent-new-world-screwworm-multiple-species-including</guid><description>FDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) infestations (myiasis).</description><pubDate>Fri, 07 Aug 2026 13:00:09 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma</title><link>http://www.fda.gov/news-events/press-announcements/fda-approves-new-engineered-viral-immunotherapy-patients-treatment-resistant-advanced-melanoma</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-approves-new-engineered-viral-immunotherapy-patients-treatment-resistant-advanced-melanoma</guid><description>The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.</description><pubDate>Thu, 06 Aug 2026 19:56:59 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms</title><link>http://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptoms</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptoms</guid><description>The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.</description><pubDate>Wed, 05 Aug 2026 19:42:58 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.</title><link>http://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-us</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-us</guid><description>FDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not…</description><pubDate>Wed, 29 Jul 2026 16:10:31 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot</title><link>http://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilot</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilot</guid><description>The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.</description><pubDate>Wed, 22 Jul 2026 17:57:57 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food</title><link>http://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-remove-outdated-authorizations-color-additives-food</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-remove-outdated-authorizations-color-additives-food</guid><description>The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make America Healthy Again.</description><pubDate>Wed, 22 Jul 2026 13:10:58 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol</title><link>http://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-pcsk9-inhibitor-lower-ldl-cholesterol-adults-high-cholesterol</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-pcsk9-inhibitor-lower-ldl-cholesterol-adults-high-cholesterol</guid><description>The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad”…</description><pubDate>Fri, 17 Jul 2026 15:01:17 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[FDA] FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horses</title><link>http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-short-term-prevention-new-world-screwworm-horses</link><guid isPermaLink="true">http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-short-term-prevention-new-world-screwworm-horses</guid><description>The FDA today issued an Emergency Use Authorization (EUA) for Ivermectin Liquid for Horses (ivermectin oral solution) for the short-term prevention of New World screwworm (NWS) infestations (myiasis) in horses when administered within 24 hours of birth or at…</description><pubDate>Wed, 15 Jul 2026 21:04:45 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health</title><link>https://www.who.int/news/item/25-02-2026-who-director-general-visits-jordan-to-recognize-strong-collaboration-on-health-system-delivery--emergency-relief-and-advancing-mental-health</link><guid isPermaLink="true">https://www.who.int/news/item/25-02-2026-who-director-general-visits-jordan-to-recognize-strong-collaboration-on-health-system-delivery--emergency-relief-and-advancing-mental-health</guid><description>The Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership between WHO and Jordan across the areas of…</description><pubDate>Wed, 25 Feb 2026 18:06:55 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] WHO statement on notification of withdrawal of the United States</title><link>https://www.who.int/news/item/24-01-2026-who-statement-on-notification-of-withdrawal-of-the-united-states</link><guid isPermaLink="true">https://www.who.int/news/item/24-01-2026-who-statement-on-notification-of-withdrawal-of-the-united-states</guid><description>WHO regrets the United States’ notification of withdrawal from WHO – a decision that makes both the United States and the world less safe. The notification of withdrawal raises issues that will be considered by the WHO Executive Board at its regular meeting…</description><pubDate>Sat, 24 Jan 2026 20:09:49 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] Paying tribute to David Nabarro</title><link>https://www.who.int/news/item/30-07-2025-paying-tribute-to-david-nabarro</link><guid isPermaLink="true">https://www.who.int/news/item/30-07-2025-paying-tribute-to-david-nabarro</guid><description>Tribute to Dr David Nabarro</description><pubDate>Wed, 30 Jul 2025 08:56:15 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] Timor-Leste certified malaria-free by WHO</title><link>https://www.who.int/news/item/24-07-2025-timor-leste-certified-malaria-free-by-who</link><guid isPermaLink="true">https://www.who.int/news/item/24-07-2025-timor-leste-certified-malaria-free-by-who</guid><description>The World Health Organization (WHO) has certified Timor-Leste as malaria-free, a remarkable achievement for a country that prioritized the disease and embarked on a concerted, nation-wide response shortly after gaining independence in 2002. “WHO congratulates…</description><pubDate>Wed, 23 Jul 2025 10:07:41 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] African Union and World Health Organization renew strategic partnership to drive impact and strengthen health systems in Africa</title><link>https://www.who.int/news/item/24-05-2025-world-health-organization-and-african-union-renew-strategic-partnership-to-drive-impact-and-strengthen-health-systems-in-africa</link><guid isPermaLink="true">https://www.who.int/news/item/24-05-2025-world-health-organization-and-african-union-renew-strategic-partnership-to-drive-impact-and-strengthen-health-systems-in-africa</guid><description>The World Health Organization (WHO) and the African Union (AU) Commission renewed their longstanding strategic partnership today with the signing of an updated Memorandum of Understanding (MoU) on the sidelines of the 78th World Health Assembly in Geneva.…</description><pubDate>Sat, 24 May 2025 17:47:21 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] WHO’s strategic engagement with philanthropies: advancing global health and resilient health systems</title><link>https://www.who.int/news/item/19-05-2025-who-s-strategic-engagement-with-philanthropies-advancing-global-health-and-resilient-health-systems</link><guid isPermaLink="true">https://www.who.int/news/item/19-05-2025-who-s-strategic-engagement-with-philanthropies-advancing-global-health-and-resilient-health-systems</guid><description>Philanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the contributions of philanthropic partners help drive…</description><pubDate>Mon, 19 May 2025 11:53:23 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] Worldwide rally for maternal and newborn health marks World Health Day 2025</title><link>https://www.who.int/news/item/10-04-2025-worldwide-rally-for-maternal-and-newborn-health-marks-world-health-day-2025</link><guid isPermaLink="true">https://www.who.int/news/item/10-04-2025-worldwide-rally-for-maternal-and-newborn-health-marks-world-health-day-2025</guid><description>On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with Member States, communities, health workers,…</description><pubDate>Thu, 10 Apr 2025 15:02:54 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[WHO] Strengthening public health across Lebanon with EIB Global</title><link>https://www.who.int/news/item/06-03-2025-strengthening-public-health-across-lebanon-with-eib-global</link><guid isPermaLink="true">https://www.who.int/news/item/06-03-2025-strengthening-public-health-across-lebanon-with-eib-global</guid><description>Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Thomas Östros, Vice-President of the European Investment Bank (EIB Global), met at the EIB Group Forum in Luxembourg and signed an agreement for a €10 million grant to…</description><pubDate>Tue, 01 Apr 2025 11:55:48 GMT</pubDate><category>Regulators &amp; agencies</category></item><item><title>[CMS] CMS Ends Federal Medicaid and CHIP Funding for Sex-Rejecting Procedures for Children and Youth</title><link>https://www.cms.gov/newsroom/press-releases/cms-ends-federal-medicaid-chip-funding-sex-rejecting-procedures-children-youth</link><guid isPermaLink="true">https://www.cms.gov/newsroom/press-releases/cms-ends-federal-medicaid-chip-funding-sex-rejecting-procedures-children-youth</guid><description>CMS Ends Federal Medicaid and CHIP Funding for Sex-Rejecting Procedures for Children and Youth The Centers for Medicare &amp; Medicaid Services (CMS) is implementing an administration priority consistent with its commitment to protect children from experimental…</description><category>Regulators &amp; agencies</category></item><item><title>[CMS] CMS Announces Resources, Flexibilities to Assist with Public Health Emergency in the State of Washington</title><link>https://www.cms.gov/newsroom/news-alert/cms-announces-resources-flexibilities-assist-public-health-emergency-state-washington</link><guid isPermaLink="true">https://www.cms.gov/newsroom/news-alert/cms-announces-resources-flexibilities-assist-public-health-emergency-state-washington</guid><description>CMS Announces Resources, Flexibilities to Assist with Public Health Emergency in the State of Washington The Centers for Medicare &amp; Medicaid Services (CMS) announced today additional resources and flexibility available in response to a Public Health Emergency…</description><category>Regulators &amp; agencies</category></item><item><title>[CMS] Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment</title><link>https://www.cms.gov/newsroom/fact-sheets/regulatory-alignment-predictable-immediate-device-coverage-pathway-cms-3487-nc-procedural-notice</link><guid isPermaLink="true">https://www.cms.gov/newsroom/fact-sheets/regulatory-alignment-predictable-immediate-device-coverage-pathway-cms-3487-nc-procedural-notice</guid><description>Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment</description><category>Regulators &amp; agencies</category></item><item><title>[CMS] CMS Launches New State Toolkit to Protect Children with Autism, Strengthen Oversight of Applied Behavior Analysis Services</title><link>https://www.cms.gov/newsroom/press-releases/cms-launches-new-state-toolkit-protect-children-autism-strengthen-oversight-applied-behavior</link><guid isPermaLink="true">https://www.cms.gov/newsroom/press-releases/cms-launches-new-state-toolkit-protect-children-autism-strengthen-oversight-applied-behavior</guid><description>CMS Launches New State Toolkit to Protect Children with Autism, Strengthen Oversight of Applied Behavior Analysis Services Resource supports child-centered, evidence-based care while strengthening program integrity, protecting children from inappropriate…</description><category>Regulators &amp; agencies</category></item><item><title>[CMS] Readout: CMS Celebrates Delivery of the Health Technology Ecosystem, One Year After Launch</title><link>https://www.cms.gov/newsroom/press-releases/readout-cms-celebrates-delivery-health-technology-ecosystem-one-year-after-launch</link><guid isPermaLink="true">https://www.cms.gov/newsroom/press-releases/readout-cms-celebrates-delivery-health-technology-ecosystem-one-year-after-launch</guid><description>Readout: CMS Celebrates Delivery of the Health Technology Ecosystem, One Year After Launch The Centers for Medicare &amp; Medicaid Services (CMS) recently hosted the one-year celebration of the Health Technology Ecosystem, bringing together leaders from the…</description><category>Regulators &amp; agencies</category></item><item><title>[CMS] FY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule (CMS-1849-F)</title><link>https://www.cms.gov/newsroom/fact-sheets/fy-2027-hospital-inpatient-prospective-payment-system-long-term-care-hospital-prospective-payment</link><guid isPermaLink="true">https://www.cms.gov/newsroom/fact-sheets/fy-2027-hospital-inpatient-prospective-payment-system-long-term-care-hospital-prospective-payment</guid><description>FY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule (CMS-1849-F)</description><category>Regulators &amp; agencies</category></item></channel></rss>